QT
SWTX

Quantamental Technologies’s SpringWorks Therapeutics SWTX Stock Holding History

Quantamental Technologies’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,011
Closed -$229K – 655
2022
Q3 		$229K Buy
+8,011
New +$230K 0.09% 380

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Quantamental Technologies's SWTX Position: Q4 2022 in Review

Quantamental Technologies sold out of SpringWorks Therapeutics (SWTX) in Q4 2022, closing a stake of 8,011 shares — an estimated $229K sold.

Quantamental Technologies first reported a position in SWTX in Q3 2022 and held it in 1 quarter. The position peaked at $229K in Q3 2022. 137 funds tracked by Wall St. Rank hold SWTX as of Q4 2022.

  • Quantamental Technologies reported no remaining SpringWorks Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 8,011 SpringWorks Therapeutics shares in Q4 2022, an estimated $229K.
  • Quantamental Technologies first reported a position in SpringWorks Therapeutics in Q3 2022 and held it in 1 quarter.
  • Quantamental Technologies's SpringWorks Therapeutics position peaked at $229K in Q3 2022.
  • 137 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.